Sudarshini Ramanathan
@darshi_r
Followers
1K
Following
2K
Media
40
Statuses
686
A/Professor of Neuroimmunology @Sydney_uni @syd_health; clinician scientist, NHMRC Investigator Fellow; Head, Translational Neuroimmunology Group
Sydney, Australia
Joined April 2020
Looking forward to this update of NMOSD diagnostic criteria and management of myasthenia gravis @thelimbicneuro with Professor Dean Wingerchuk and A/Professor Kath Buzzard @syd_health
TONIGHT: https://t.co/gZWuzfJ3YP Join online as expert neurologists present the latest updates on the NMOSD diagnostic criteria and explore treatment strategies for myasthenia gravis. Host: @darshi_r
1
0
6
TSF’s 2025 Global Rare Trailblazer Award recognized Prof. Vanda Lennon in Barcelona during ECTRIMS for her groundbreaking neuroimmunology research. Her discovery of key autoantibodies has advanced diagnosis & care for autoimmune neurological disorders. https://t.co/8pqag4f6jA
0
7
18
If you’re a woman >18 with #MOGAD or #NMOSD, we would like you to complete this survey to better understand family planning, pregnancy &/or postpartum in MOGAD & NMOSD! Survey in English: https://t.co/agCuYmMUBV Our international team: @EthelScl, @mlevy18, @chenmayo,
docs.google.com
Dear participant, We warmly invite you to take part in a voluntary and anonymous survey designed for women diagnosed with Neuromyelitis Optica Spectrum Disorder (NMOSD) or MOG Antibody-Associated...
0
9
10
Who is a spectacularly good #antibody - #protein #biochemist? and wants to work on: 1. #Neuroimmune diseases 🧫 🧬 2. A translational environment @Mayo Clinic 🏥 🧑⚕️ 3. In Florida ☀️🏝️🏖️ 4. With an amazing lab team 👏🏼 If it’s you, please click here ⬇️ https://t.co/TIBLDJ7nB7
fa-euwp-saasfaprod1.fa.ocs.oraclecloud.com
The laboratory of Dr. Irani is seeking a highly motivated Postdoctoral Research Fellow to join the Protein Engineering and Biochemistry in Autoimmune Neurology Group in Jacksonville, Florida. This...
2
7
16
Congratulations to @AnneProbstel Veronique Miron & Qiang Liu, the 3 #ISNI #WeAreNeuroimmunology Mid-Career Awardees! Fantastic talks at #ISNI2025 and bright future in neuroimmunological research. 🎉 @hwiendl @FabienneBrilot
1
2
18
What a historic evening at #ISNI2025 in Chiba! Heard Dr. Shimon Sakaguchi’s inspiring talk on Treg, & just hours later, he won the 2025 #NobelPrize in medicine The neuroimmunology community erupted in cheers at the gala! #weareneuroimmunology #AshuLiveFromChiba #NobelPrize2025
4
28
232
Our meta analysis of biomarkers predicting relapse in #MOGAD is out! https://t.co/dm9nhEF6go Relapsing course associated with: ➡️persistent MOG-IgG seropositivity ➡️delayed seroreversion Higher risk of attack associated with: ➡️ higher MOG-IgG titer ➡️CSF leucocytosis @darshi_r
3
12
30
Such an honor to host the great Amit Bar-Or from @PennNeurology as visiting faculty at @MayoClinicNeuro to talk on the immunolobiology of #MS ➡️A wonderful person, outstanding researcher and superb mentor of trainees ➡️ A role model for all of us 👇
0
6
53
Proud to have contributed to this @NatureComms study! 🙌 We identify neuron-reactive CD8⁺ T cells and reveal how KIR⁺CD8⁺ T cells become dysregulated in Ri-AIE, shedding light on T cell–driven CNS autoimmunity 🧠✨ Read here:
nature.com
Nature Communications - Autoimmune encephalitis (AIE) may involve neuron-specific cytotoxic T cells, but evidence is still lacking. Here the authors use induced pluripotent stem cells from patients...
0
4
15
Had the best time at #ECTRIMS2025 with amazing colleagues near & far. So thankful for advancement in research in #MOGAD & the wonderful avenues our wonderful scientists & Drs are exploring to help expedite treatment decisions & diagnosis with MOGAD! @UCBMedia, @darshi_r,
1
2
12
Discussing current and emerging treatments in #NMOSD and #MOGAD. Great talk by @darshi_r at #ECTRIMS2025. @TheMOGProject @TheSumairaFDN
0
4
18
The last decade has seen marked advancements in therapeutic options in NMOSD. There is much work to be done in MOGAD to provide evidence-based guidance on when to start treatment, which therapeutic strategies are most efficacious, and when to de-escalate/discontinue treatment.
1
0
5
Pleased to review current and emerging therapeutic strategies in NMOSD and MOGAD @ECTRIMS 2025 @syd_health
Ramanathan: #MOGAD maintenance treatments currently used include IVIG, rituximab and tocilizumab without phase 3 trial supportive data. New treatments in development; see below 👇 #ECTRIMS2025
1
2
12
Check out our STAR-MOG investigator led phase III RCT in MOGAD presented by @IzzyCotter at the @ECTRIMS poster session today! @syd_health @TheMOGProject @MS_Australia @TheSumairaFDN
1
6
20
At #ECTRIMS2025? Join the #iWiMS reception to hear from our international panel @darshi_r @EthelScl Noriko Isobe JackiePalace Antje Bischof Malya Sahu & Sibongile Tito, and welcome @KristenKryskoMD, #RachelHornePrize winner 2025! Hilton Diagonal Mar Ballroom A1+A2 at 6:30pm
0
5
9
Good news story for #MOGAD ➡️ High concordance in flow live MOG-IgG testing between conventional/full spectrum, research/diagnostic flow cytometers ➡️ Flow live CBA can be validated for diagnostic purposes @darshi_r @syd_health @BrainMind_Usyd
https://t.co/Wasen4VkF9
0
9
21
Thank you to @MS_Australia for this great piece. ➡️ COVID-19 VAX boosters improve the longevity and cross-variant breadth of immune responses in #MS ➡️ machine-learning models predict protection or need of an extra booster. @anneke_vdw @darshi_r @StuartTurville @syd_health
A new Australian study shows COVID-19 boosters improve protection against new variants for people with #MS, even when taking immune-suppressing treatments. Read more 👇
0
4
10
Thrilled to share the 2024 revisions of the diagnostic Mc Donald criteria and companion papers @ECTRIMS @mssociety @MSIntFederation @vallhebron @FundacioEM @esclerosiseme @cemcat_em @ACTRIMS @EuropeanCharcot @TheLancetNeuro @UABBarcelona @u_medicina
linkedin.com
Thrilled to share the 2024 revisions of the diagnostic Mc Donald criteria for #MultipleSclerosis – published today I’m absolutely delighted to announce the publication of the 2024 revisions of the...
1
31
70
It’s out! Updates to ensure the critical balance between sensitivity and making an earlier diagnosis of MS vs specificity and avoiding misdiagnosis. A privilege to learn from and contribute to the amazing group behind this. @ECTRIMS @mssociety @XMontalban @syd_health
📢 Breaking news: The 2024 revised #McDonaldCriteria have been published in @TheLancetNeuro. Explore the latest evidence shaping #MSDiagnosis. Published by the International Advisory Committee for Clinical Trials in #MS. 👉 https://t.co/8V2lWodMm2
@mssociety #MSResearch #IACCTMS
0
2
2
1/5 The long-awaited 2024 McDonald criteria are now published! I’m proud to see that our work at @UCLIoN @UCLHresearch has helped to change the way MS is diagnosed, and that our patients will now benefit from earlier diagnosis and treatment @olgacicc
https://t.co/6jRaFnSaAT
1
19
47